<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75191</article-id><article-id pub-id-type="doi">10.7554/eLife.75191</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Multi-targeted therapy resistance via drug-induced secretome fucosylation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-263386"><name><surname>Aldonza</surname><given-names>Mark Borris D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-307233"><name><surname>Cha</surname><given-names>Junghwa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-263388"><name><surname>Yong</surname><given-names>Insung</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7828-4264</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-263385"><name><surname>Ku</surname><given-names>Jayoung</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4112-4582</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110100"><name><surname>Sinitcyn</surname><given-names>Pavel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2653-1702</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263384"><name><surname>Lee</surname><given-names>Dabin</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263389"><name><surname>Cho</surname><given-names>Ryeong-Eun</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263390"><name><surname>Delos Reyes</surname><given-names>Roben D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1368-6817</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263391"><name><surname>Kim</surname><given-names>Dongwook</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-263392"><name><surname>Kim</surname><given-names>Soyeon</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263393"><name><surname>Kang</surname><given-names>Minjeong</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263394"><name><surname>Ku</surname><given-names>Yongsuk</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263395"><name><surname>Park</surname><given-names>Geonho</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307234"><name><surname>Sung</surname><given-names>Hye-Jin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-263396"><name><surname>Ryu</surname><given-names>Han Suk</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263397"><name><surname>Cho</surname><given-names>Sukki</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263398"><name><surname>Kim</surname><given-names>Tae Min</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-118118"><name><surname>Kim</surname><given-names>Pilnam</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5592-4599</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" corresp="yes" id="author-184910"><name><surname>Cho</surname><given-names>Je-Yoel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" corresp="yes" id="author-253714"><name><surname>Kim</surname><given-names>Yoosik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3064-4643</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf9"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff2"><institution content-type="dept">Department of Bio and Brain Engineering</institution>, <institution>Korea Advanced Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Daejeon</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff3"><institution content-type="dept">Computational Systems Biochemistry Research Group</institution>, <institution>Max Planck Institute of Biochemistry</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Department of Chemical and Biomolecular Engineering</institution>, <institution>Korea Advanced Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Daejeon</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff5"><institution content-type="dept">Comparative Medicine Disease Research Center</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff6"><institution content-type="dept">Department of Electrical Engineering</institution>, <institution>Korea Advanced Institute of Science and Technology</institution>, <addr-line><named-content content-type="city">Daejeon</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff7"><institution content-type="dept">Department of Internal Medicine</institution>, <institution>Seoul National University Hospital</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff8"><institution content-type="dept">Department of Pathology</institution>, <institution>Seoul National University Hospital</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff9"><institution content-type="dept">Department of Thoracic and Cardiovascular Surgery</institution>, <institution>Seoul National University Bundang Hospital</institution>, <addr-line><named-content content-type="city">Seongnam</named-content></addr-line>, <country>Republic of Korea</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-142305"><name><surname>Narla</surname><given-names>Goutham</given-names></name><role>Reviewing editor</role><aff><institution>University of Michigan</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>pkim@kaist.ac.kr</email> (PK);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>jeycho@snu.ac.kr</email> (JC);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>ysyoosik@kaist.ac.kr</email> (YK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e75191</elocation-id><history><date date-type="received"><day>02</day><month>11</month><year>2021</year></date><date date-type="accepted"><day>22</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Aldonza et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Aldonza et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75191-v1.pdf"/><abstract><p>Cancer secretome is a reservoir for aberrant glycosylation. How therapies alter this post- translational cancer hallmark and the consequences thereof remain elusive. Here we show that an elevated secretome fucosylation is a pan-cancer signature of both response and resistance to multiple targeted therapies. Large-scale pharmacogenomics revealed that fucosylation genes display widespread association with resistance to these therapies. In cancer cell cultures, xenograft mouse models, and patients, targeted kinase inhibitors distinctively induced core fucosylation of secreted proteins less than 60 kDa. Label-free proteomics of N-glycoproteomes identified fucosylation of the antioxidant PON1 as a critical component of the therapy-induced secretome (TIS). N-glycosylation of TIS and target core fucosylation of PON1 are mediated by the fucose salvage-FUT8-SLC35C1 axis with PON3 directly modulating GDP-Fuc transfer on PON1 scaffolds. Core fucosylation in the Golgi impacts PON1 stability and folding prior to secretion, promoting a more degradation-resistant PON1. Global and PON1-specific secretome de-N-glycosylation both limited the expansion of resistant clones in a tumor regression model. We defined the resistance-associated transcription factors (TFs) and genes modulated by the N-glycosylated TIS via a focused and transcriptome-wide analyses. These genes characterize the oxidative stress, inflammatory niche, and unfolded protein response as important factors for this modulation. Our findings demonstrate that core fucosylation is a common modification indirectly induced by targeted therapies that paradoxically promotes resistance.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007107</institution-id><institution>Korea Advanced Institute of Science and Technology</institution></institution-wrap></funding-source><award-id>N11190234</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Yoosik</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2019R1C1C1006672</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Yoosik</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2018R1A6A3A01012494</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Pilnam</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2016M3A9B6026771</award-id><principal-award-recipient><name><surname>Cho</surname><given-names>Je-Yoel</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2021R1A5A1033157</award-id><principal-award-recipient><name><surname>Cho</surname><given-names>Je-Yoel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Mark Borris D Aldonza, There is currently a pending patent filing for the biomarker signature revealed in this study for which MBDA is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf3"><p>Junghwa Cha, There is currently a pending patent filing for the biomarker signature revealed in this study for which JC is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf4"><p>Insung Yong, There is currently a pending patent filing for the biomarker signature revealed in this study for which IY is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf5"><p>Dongwook Kim, is currently employed at ProtanBio Inc., a disease biomarker venture company of Seoul National University. The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf6"><p>Hye-Jin Sung, is currently employed at ProtanBio Inc., a disease biomarker venture company of Seoul National University. The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf7"><p>Pilnam Kim, There is currently a pending patent filing for the biomarker signature revealed in this study for which PK is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf8"><p>Je-Yoel Cho, There is currently a pending patent filing for the biomarker signature revealed in this study for which J-YC is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). J-YC is CEO of ProtanBio Inc., a disease biomarker venture company of Seoul National University. The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf9"><p>Yoosik Kim, There is currently a pending patent filing for the biomarker signature revealed in this study for which Yoosik K is listed as an inventor (application number: 10-2021-0048888 (2021-04-15)). The authors declare that they have no other competing interests..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: All human blood and tissues from three cohorts of patients diagnosed to have lung adenocarcinoma or squamous cell carcinoma or breast carcinoma were collected and analyzed with approved protocols in accordance with the ethical requirements and regulations of the Institutional Review Board of Seoul National University Hospital after securing written informed consent (IRB Nos. 1104-086-359 and B-1201/143-003).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All sequencing data produced for this publication has been deposited to the NCBI Gene Expression Omnibus (GEO) database under the accession number GSE160205. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022240. Source Data 1 contains raw images of blots and gels. Other data associated with this study are present in the paper, Supplementary Materials, or source data files. Additional data related to this paper may be requested from M.B.D.A., Yoosik K., or J.Y.C. Reagents, and cell lines described here are accessible through a materials transfer agreement.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Aldonza MD</collab><collab>Ku J</collab><collab>Kim Y</collab></person-group><year iso-8601-date="2020">2020</year><source>Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160205">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160205</ext-link><comment>NCBI Gene Expression Omnibus, GSE160205</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Pavel Sinitcyn</collab><collab>Yoosik Kim</collab></person-group><year iso-8601-date="2020">2020</year><source>Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD022240">https://www.ebi.ac.uk/pride/archive/projects/PXD022240</ext-link><comment>PRIDE, PXD022240</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Francesco Iorio</collab></person-group><year iso-8601-date="2013">2013</year><source>Genomics of Drug Sensitivity in Cancer</source><ext-link ext-link-type="uri" xlink:href="https://www.cancerrxgene.org/">https://www.cancerrxgene.org/</ext-link><comment>PMID: 23180760</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Cancer Cell Line Encyclopedia Consortium</collab></person-group><year iso-8601-date="2015">2015</year><source>Cancer Cell Line Encyclopedia</source><ext-link ext-link-type="uri" xlink:href="https://sites.broadinstitute.org/ccle">https://sites.broadinstitute.org/ccle</ext-link><comment>PMID: 26570998</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>DepMap Consortium</collab></person-group><year iso-8601-date="2017">2017</year><source>DepMap</source><ext-link ext-link-type="uri" xlink:href="https://depmap.org/portal/">https://depmap.org/portal/</ext-link><comment>PMID: 28753430</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-75191-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>